CHE Roto-Rooter: מכפיל EV/EBITDA

Chemed Corporation (CHE) stability is based on its ownership of crisis-resistant monopolies in the plumbing and hospice sectors. The EV/EBITDA valuation level helps filter out market noise, while the 17.00 indicator determines the magnitude of the metric. Expansion of reach is driven by B2B contracts and partnerships with clinics. Steady cash flow and high operational activity confirm the long-term viability of both business models.

Chemed Corporation (CHE) is transforming medicine through the implementation of AI algorithms and remote monitoring, which requires significant R&D capital expenditures. The current EV/EBITDA metric, including debt, relates the company's market value and liabilities to its operating profit, allowing for an assessment of the business's real margin of safety. Analyzing this metric helps investors determine the degree of fundamental asset undervaluation relative to their ability to generate cash flow.